South Korea Liquid Biopsy Services Market was valued at USD 0.40 Billion in 2022 and is projected to reach USD 0.85 Billion by 2030, growing at a CAGR of 10.45% from 2024 to 2030.
South Korea’s Liquid Biopsy Services Market has been gaining significant attention in recent years, driven by the demand for non-invasive cancer diagnostics and personalized medicine. Liquid biopsy, a revolutionary technique that analyzes biomarkers in body fluids like blood, offers a less invasive and faster alternative to traditional tissue biopsies. As technology advances, this market is expected to experience exponential growth. The need for such services is being fueled by the increasing prevalence of cancer and the desire for early-stage detection, which can lead to better outcomes for patients.
The South Korean healthcare sector has been at the forefront of adopting cutting-edge technologies, including liquid biopsy services. The country’s strong healthcare infrastructure, coupled with significant investments in research and development, has made it a leader in providing liquid biopsy testing. Medical institutions and diagnostic laboratories across the nation are incorporating liquid biopsy tests to detect various types of cancers such as lung, breast, and colorectal cancers. These services are being driven by the increasing number of patients seeking faster, less invasive diagnostic methods.
Industries requiring liquid biopsy services include hospitals, research institutions, pharmaceutical companies, and diagnostic centers. Hospitals and medical institutions are utilizing these services to offer cancer screening and monitoring for patients. Research institutions rely on liquid biopsy for precision medicine studies, developing targeted therapies for cancer. Additionally, pharmaceutical companies are using liquid biopsy testing for clinical trials, enabling them to develop new drugs and treatments based on specific patient profiles. Diagnostic centers play a critical role in providing the necessary testing and analysis for early detection and disease management.
The growing interest in liquid biopsy services in South Korea can also be attributed to the increasing focus on personalized medicine. Patients are becoming more proactive in their healthcare, demanding more accurate and individualized treatment plans. This trend has been fueled by the country’s well-established digital infrastructure and the government’s efforts to foster innovation in the medical field. With significant investments in the healthcare sector, the South Korean market for liquid biopsy services is poised for continued growth, further enhancing its role in the fight against cancer.
With advancements in technology and increased healthcare spending, liquid biopsy services are expected to become a crucial tool in both early cancer detection and personalized treatment plans. This market's expansion will not only benefit patients but also strengthen South Korea's position as a leader in the global healthcare sector.
Get an In-Depth Research Analysis of the South Korea Liquid Biopsy Services Market Size And Forecast [2025-2032]
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
OME Care
NeoGenomics Laboraories
Sysmex Inostics
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Liquid Biopsy Services Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Liquid Biopsy Services Market
Blood Samples
Urine Samples
Saliva Samples
Tissue Samples
Cancer Diagnostics
Monitoring Therapy Response
Recurrence Monitoring
Drug Development
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Circulating Tumor Cell (CTC) Analysis
Microfluidics
Hospitals
Diagnostic Laboratories
Research Institutions
Pharmaceutical Companies
Testing Services
Analysis Services
Consultation Services
Data Management Services
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Liquid Biopsy Services Market Research Analysis
1. Introduction of the South Korea Liquid Biopsy Services Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Liquid Biopsy Services Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Liquid Biopsy Services Market, By Type
6. South Korea Liquid Biopsy Services Market, By Application
7. South Korea Liquid Biopsy Services Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Liquid Biopsy Services Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/